Here’s an interesting tidbit from Nir Barzilai’s centenarian study. Centenarians have lower IGF-1 levels than is typical. I believe rapamycin will drop IGF1
AI Summary of video added by @RapAdmin
I. Executive Summary
This presentation by Dr. Nir Barzilai evaluates the genetic and physiological architecture of human longevity derived from the Albert Einstein College of Medicine’s centenarian cohort studies. The core inquiry dissects three foundational hypotheses regarding extreme longevity (reaching ages 95–100+): (1) environmental and lifestyle optimization, (2) the absence of pathogenic disease-associated genetic alleles, and (3) active genetic mechanisms that decelerate intrinsic biological aging.
The empirical data systematically refutes the first two hypotheses. Epidemiological profiling of centenarians against age-matched historical cohorts, such as NHANES I (Rajpathak et al., 2011), reveals that centenarians engaged in equal or worse health behaviors relative to the general population. Approximately 60% of male and 30% of female centenarians had histories of heavy, long-term tobacco use; ~50% presented with overweight or obesity; fewer than 50% engaged in routine moderate physical activity; and only 2% adhered to vegetarian dietary patterns. Furthermore, their first-degree offspring exhibited a 50% reduction in cardiovascular disease incidence compared to controls despite sharing identical socioeconomic backgrounds, physical activity levels, and macronutrient intake.
Whole-genome sequencing cross-referenced against variant databases (e.g., ClinVar) disproved the “perfect genome” hypothesis. Centenarians carried an average of five major pathogenic disease alleles, including homozygous APOE4genotypes, without manifesting expected clinical endpoints such as premature cardiovascular death or early-onset Alzheimer’s dementia.
Instead, human longevity is driven by protective gene variants that actively buffer against pathogenic exposures and suppress cellular aging mechanisms. Foremost among these is the downregulation of the somatotropic axis. Over 60% of centenarians possess functional mutations attenuating growth hormone (GH) and insulin-like growth factor 1 (IGF-1) receptor signaling (Suh et al., 2008). This biological phenotype conforms to the evolutionary framework of antagonistic pleiotropy (Zhang et al., 2021): high GH/IGF-1 signaling optimizes somatic development and reproductive fitness during early life, but accelerates oncogenesis, vascular deterioration, and all-cause mortality in post-reproductive aging. Consequently, lower circulating IGF-1 in advanced age directly correlates with extended survival, preserved cognition, and reduced multimorbidity.
II. Insight Bullets
- Cohort Expansion and Statistical Power: The initial Ashkenazi Jewish longevity study analyzed ~750 centenarians and their immediate families; ongoing research initiatives coordinated with the American Federation for Aging Research (AFAR) aim to scale validation to 10,000 centenarians to map rare protective loci.
- Hypothesis 1 (Lifestyle Adherence): The premise that centenarians achieve exceptional lifespan via pristine diet, exercise, or environmental restriction (e.g., “Blue Zone” models) is empirically invalid.
- Heavy Tobacco Exposure: Tobacco use was prevalent across the centenarian cohort (60% of men and 30% of women were chronic heavy smokers), including extreme outliers such as individuals smoking daily past age 110.
- Metabolic and Adiposity Metrics: Half of the studied centenarians were classified as overweight or obese during their adult lives and into their centenarian years, contradicting strict low-BMI longevity dogmas.
- Sedentary Baseline: Less than 50% of the centenarians engaged in regular moderate physical activities (such as dedicated walking, cycling, or physical labor) throughout middle and older age.
- Negligible Vegetarianism: Vegetarian dietary patterns represented only 2% of the centenarian cohort, showing no overrepresentation compared to baseline population cohorts.
- Epidemiological Parity with NHANES I: Direct comparison of centenarian lifestyle data with the NHANES I population survey demonstrated identical or occasionally worse behavioral metrics among the exceptionally long-lived (Rajpathak et al., 2011).
- Familial Cardiovascular Protection: Offspring of centenarians demonstrate a 50% lower rate of cardiovascular disease compared to age- and demographically-matched controls lacking familial longevity.
- Decoupling of Diet and Offspring Phenotype: Comprehensive nutritional tracking revealed that the 50% CVD reduction in centenarian offspring occurred despite macronutrient profiles, caloric intake, and body mass index being identical to controls.
- Hypothesis 2 (Absence of Disease Alleles): The premise that centenarians reach extreme age due to an absence of high-risk disease variants is false.
- Pathogenic Variant Burden: Initial whole-genome sequencing of 44 centenarians revealed ~250 disease-associated genetic variants cataloged in ClinVar, averaging roughly 5 distinct disease-causing variants per individual.
- Penetrance Escape in APOE4: Individuals homozygous for the APOE4 allele—a genotype typically associated with high rates of Alzheimer’s dementia and accelerated mortality before age 80—were identified at age 100+ cognitively intact.
- The Buffering Hypothesis: Centenarians possess active protective genetic mechanisms that suppress the phenotypic penetrance of high-risk pathogenic alleles.
- Hypothesis 3 (Active Longevity Genes): Human life extension and healthspan compression are mediated by specific genetic variations that actively suppress fundamental pathways of cellular aging.
- Preponderance of GH/IGF-1 Axis Mutations: Approximately 60% of centenarians harbor functional, loss-of-function mutations or downregulating variations across the growth hormone / IGF-1 signaling cascade (Suh et al., 2008).
- Metabolic Shift to Somatic Maintenance: Suppression of growth hormone signaling redirects systemic biological resources away from continuous cellular growth and proliferation toward cellular maintenance, repair, and stress defense.
- Antagonistic Pleiotropy Mechanics: The somatotropic pathway exemplifies antagonistic pleiotropy—favoring robust growth, development, and fecundity early in life, but driving degenerative pathology, hyperproliferation, and senescence in late adulthood.
- Population Evidence in UK Biobank: Large-scale analysis of over 440,000 individuals in the UK Biobank confirms that while higher IGF-1 protects against specific mortalities in youth, elevated IGF-1 in older adults accelerates all-cause mortality and chronic disease progression (Zhang et al., 2021).
- Serum IGF-1 and Late-Life Survival: Female centenarians with serum IGF-1 levels in the lowest distribution tertile demonstrate a two-fold increase in survival duration relative to female centenarians with high circulating IGF-1.
- Cognitive Preservation via Somatotropic Attenuation: Lower IGF-1 signaling in advanced age is associated with superior scores across objective cognitive function assessments.
- Comparative Mammalian Biology: Natural mammalian size variation demonstrates an inverse relationship between somatotropic axis activity and longevity; smaller dog breeds, ponies, and smaller rodent phenotypes consistently outlive larger conspecifics.
- Laron Syndrome Clinical Model: Growth hormone receptor deficiency (GHRD/Laron syndrome) in humans results in severe IGF-1 deficiency, conferring near-complete protection against malignant neoplasms and type 2 diabetes mellitus (Guevara-Aguirre et al., 2011).
- Translational Target Validation: Because centenarian biology demonstrates that genetic down-modulation of growth signaling slows human aging, pharmacological modulation of these conserved nutrient-sensing pathways represents a primary target for geroprotective medicine (Barzilai et al., 2023).